BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 193 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2018. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $175,971 | -16.0% | 3,504 | +5.7% | 0.01% | -10.0% |
Q2 2023 | $209,508 | +40.5% | 3,315 | 0.0% | 0.01% | +25.0% |
Q1 2023 | $149,142 | -7.4% | 3,315 | -9.8% | 0.01% | +14.3% |
Q4 2022 | $161,089 | -33.5% | 3,677 | 0.0% | 0.01% | -41.7% |
Q3 2022 | $242,278 | +30.4% | 3,677 | 0.0% | 0.01% | +50.0% |
Q2 2022 | $185,725 | -20.9% | 3,677 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $234,887 | -85.3% | 3,677 | -75.3% | 0.01% | -63.6% |
Q4 2021 | $1,595,082 | +1.2% | 14,892 | -2.8% | 0.02% | -4.3% |
Q3 2021 | $1,575,666 | +11.6% | 15,326 | -4.5% | 0.02% | +15.0% |
Q2 2021 | $1,411,934 | -3.5% | 16,052 | +6.7% | 0.02% | -9.1% |
Q1 2021 | $1,463,214 | -16.3% | 15,049 | -3.5% | 0.02% | -15.4% |
Q4 2020 | $1,748,643 | +19.9% | 15,592 | -0.9% | 0.03% | +4.0% |
Q3 2020 | $1,457,986 | +13.4% | 15,728 | -4.6% | 0.02% | +8.7% |
Q2 2020 | $1,286,142 | +35.3% | 16,489 | +1.5% | 0.02% | +15.0% |
Q1 2020 | $950,475 | -23.4% | 16,253 | +4.9% | 0.02% | -4.8% |
Q4 2019 | $1,241,304 | +5.9% | 15,495 | -2.9% | 0.02% | +5.0% |
Q3 2019 | $1,172,067 | -16.5% | 15,953 | +7.2% | 0.02% | -16.7% |
Q2 2019 | $1,403,158 | +31.8% | 14,875 | +11.9% | 0.02% | +26.3% |
Q1 2019 | $1,064,425 | +46.5% | 13,297 | -1.3% | 0.02% | +26.7% |
Q4 2018 | $726,491 | -30.9% | 13,476 | 0.0% | 0.02% | -21.1% |
Q3 2018 | $1,051,937 | -99.9% | 13,476 | 0.0% | 0.02% | +35.7% |
Q2 2018 | $855,456,000 | -30.8% | 13,476 | 0.0% | 0.01% | -17.6% |
Q1 2018 | $1,235,750,000 | +129162.6% | 13,476 | +6.3% | 0.02% | +30.8% |
Q4 2017 | $956,000 | -47.8% | 12,672 | -51.8% | 0.01% | +18.2% |
Q3 2017 | $1,831,000 | +36.1% | 26,279 | -1.0% | 0.01% | +22.2% |
Q2 2017 | $1,345,000 | +96.1% | 26,542 | +54.7% | 0.01% | +80.0% |
Q1 2017 | $686,000 | +57.0% | 17,155 | +10.2% | 0.01% | +66.7% |
Q4 2016 | $437,000 | -5.4% | 15,566 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $462,000 | +46.7% | 15,566 | 0.0% | 0.00% | +50.0% |
Q2 2016 | $315,000 | +110.0% | 15,566 | +87.9% | 0.00% | +100.0% |
Q1 2016 | $150,000 | -35.9% | 8,285 | -6.7% | 0.00% | -50.0% |
Q4 2015 | $234,000 | +23.2% | 8,883 | 0.0% | 0.00% | +100.0% |
Q3 2015 | $190,000 | -19.8% | 8,883 | -0.8% | 0.00% | -50.0% |
Q2 2015 | $237,000 | – | 8,954 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |